XSHE
002141
Market cap945mUSD
Oct 09, Last price
5.72CNY
1D
-6.69%
1Q
11.07%
Jan 2017
-43.01%
IPO
66.34%
Name
Infund Holding Co Ltd
Chart & performance
P/E
376.40
P/S
5.12
EPS
0.02
Div yield, %
—
Shrs. gr., 5y
-2.01%
Rev. gr., 5y
-4.71%
Revenues
1.15b
+162.19%
Net income
16m
P
CFO
55m
P
Dividend
Jul 13, 20180.001 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Infund Holding Co., Ltd. engages in the production and sales of copper clad laminates, feed, and veterinary vaccines and related technical services in China. The company offers animal nutrition; copper-clad, a plate-like material made of reinforcing materials, such as glass fiber cloth, paper base used in electrical appliances, home appliances, electronic information, involving industrial control, communication equipment, automotive electronics, security electronics, medical equipment, consumer electronics, computers and servers, transportation, aerospace and other fields. It provides vaccines for pigs, including blue ear, pseudorabies, porcine viral diarrhea and mycoplasma pneumonia diseases. In addition, it offers equity investment, asset management, external investment; and feed, biological vaccines. Infund Holding Co., Ltd. was founded in 1985 and is headquartered in Dongguan, China.
Key people
Wencai Chen
Chairman of the Board · since 2017
Min Lu
General Manager, Director · since 2017
Junjun Peng
Chief Financial Officer, Deputy General Manager · since 2017
Jia Yang
Deputy General Manager · since 2012
Zhigang Zhang
Secretary of the Board, Deputy General Manager · since 2010
Qibin Liu
Director · since 2011
Qingguo Gao
Independent Director · since 2011
Qinghui Zhuo
Independent Director · since 2008
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||